-transparent.png){kind=logo}
1. Four weeks of glyburide (glibenclamide) treatment (5 mg/kg, orally) was administered in type II diabetic rats and the effect of such treatment was determined on muscle glutathione peroxidase (GPx) activity. 2. GPx activity was measured by a spectrophotometric method in which its activity was coupled to the oxidation of NADPH by glutathione reductase. 3. No statistically significant difference was found in muscle GPx activity between diabetic rats and controls. 4. There was a significant difference in GPx activity between glyburide-treated diabetic and nontreated diabetic groups and between glyburide-treated control and control groups. 5. The results of this study demonstrated that diabetes did not significantly alter skeletal muscle GPx activity in diabetic rats. However, glyburide may be an effective antioxidant agent in addition to its expected insulin-like effects.
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
September 1994,
General pharmacology,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
January 2009,
Journal of diabetes and its complications,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
September 2004,
Methods and findings in experimental and clinical pharmacology,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
August 1998,
General pharmacology,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
December 2006,
Acta diabetologica,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
January 1994,
Diabetes research and clinical practice,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
October 1994,
General pharmacology,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
November 1994,
General pharmacology,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
August 1998,
Brain research bulletin,
N Kiliç, and
E Malhatun, and
E Elmali, and
N Altan
September 1996,
Molecular and cellular biochemistry,
